Walleye Trading LLC Solid Biosciences Inc. Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $15,062 - $23,781	-4,316 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $23,176 - $46,267	4,316 New	4,316 $24,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $30,405 - $46,360	-15,052 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $31,609 - $51,477	15,052 New	15,052 $44,000
Q1 2020 May 15, 2020	SELL	$2.31 - $4.43 $50,820 - $97,460	-22,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $62,040 - $283,800	22,000 New	22,000 $98,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $161,244 - $433,461	-37,239 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $171,299 - $377,231	37,239 New	37,239 $214,000
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $14,924 - $32,438	-700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$36.35 - $51.7 $25,445 - $36,190	700 New	700 $33,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.